| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/07/2004 | EP1377558A1 [1,4]-diazepane-1-carboxylic acid derivatives, process for their preparation and their use as tachykinin antagonists |
| 01/07/2004 | EP1377555A1 Novel compounds |
| 01/07/2004 | EP1377550A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
| 01/07/2004 | EP1377540A1 INHIBITORS OF INTEGRIN AvB6 |
| 01/07/2004 | EP1377319A2 Fusion proteins |
| 01/07/2004 | EP1377318A2 Pregabalin lactose conjugates |
| 01/07/2004 | EP1377311A2 Treatment of neuropathologies associated with expression of tnf-alpha |
| 01/07/2004 | EP1377295A2 Carboxamide derivatives as therapeutic agents |
| 01/07/2004 | EP1377294A2 Use of neuroactive substances for the treatment of parkinsons disease and pharmaceutical combination |
| 01/07/2004 | EP1377288A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method |
| 01/07/2004 | EP1377287A2 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases |
| 01/07/2004 | EP1377286A1 Treatment of schizophrenia |
| 01/07/2004 | EP1377285A1 Pharmaceutical composition comprising ibuprofen and prochlorperazine |
| 01/07/2004 | EP1377282A2 Aryl-n-cyanoguanidines and methods related thereto |
| 01/07/2004 | EP1377276A2 Timed pulse release composition |
| 01/07/2004 | EP1377164A1 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 01/07/2004 | EP1294388B1 Extracts from sophora species, method for producing the same and their use |
| 01/07/2004 | EP1289997B1 Macrolides |
| 01/07/2004 | EP1175417B1 Substituted benzolactam compounds |
| 01/07/2004 | EP1103243B1 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives for the treatment of troubles mediated by an excess of substance p |
| 01/07/2004 | EP1082119B1 Microemulsion preconcentrates containing a piperidine substance p antagonist |
| 01/07/2004 | EP1056733B1 Histamine h3 receptor ligands |
| 01/07/2004 | EP1033988B1 Parenteral formulations comprising 10-hydroxy-10,11-tetrahydrocarbamazepine, water and glucose |
| 01/07/2004 | EP0949925B1 Flat medicament preparation for the application and release of buprenorphine or a pharmacologically comparable substance in the buccal cavity, and method of producing the same |
| 01/07/2004 | EP0944611B1 Dimesylate salts of neuropeptide y ligands |
| 01/07/2004 | EP0719152B1 Novel therapeutic and dietetic uses of a brain phospholipid-based complex |
| 01/07/2004 | CN1466680A Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 01/07/2004 | CN1466594A Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/07/2004 | CN1466587A Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |
| 01/07/2004 | CN1466577A 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 01/07/2004 | CN1466576A Quinolne-(C=O)-CD1, tri-and tetrapeptide) derivatives as caspase inhibitors |
| 01/07/2004 | CN1466575A Quinolene derivatives as anti-inflammation agents |
| 01/07/2004 | CN1466573A 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis |
| 01/07/2004 | CN1466569A Novel 3-substituted urea derivatives and medicinal use thereof |
| 01/07/2004 | CN1466567A Substituted 1-aminobutan-3-01 derivatives |
| 01/07/2004 | CN1466467A Pharmaceutical composition and method for treating hypogonadism |
| 01/07/2004 | CN1466456A Sgk2 and Sgk3 used as diagnostic and therapeutic targets |
| 01/07/2004 | CN1466455A Fentanyl composition for nasal administration |
| 01/07/2004 | CN1466451A Ion-strength independent sustained release pharmacetuical formulation |
| 01/07/2004 | CN1465566A Sinomenine Hydrochloride and its compound, synthesis and use |
| 01/07/2004 | CN1465389A Daqinglong decoction and preparation thereof |
| 01/07/2004 | CN1133648C Substituted phenylalamine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/07/2004 | CN1133636C Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
| 01/07/2004 | CN1133633C Method for prepn. of citalopram |
| 01/07/2004 | CN1133622C Ureidopiperidine derivatives as selective human NK3 receptor antagonists |
| 01/07/2004 | CN1133464C Pharmaceutical compositions for controlled release of soluble receptors |
| 01/07/2004 | CN1133443C Medicine for treating senile dementia and preparation process thereof |
| 01/07/2004 | CN1133427C Solid oral dosage forms of valsartan |
| 01/07/2004 | CN1133425C Use of adamantane amines or structurally similar compounds in preparation of medicinal composition |
| 01/06/2004 | US6673838 Succinate salt of O-desmethyl-venlafaxine |
| 01/06/2004 | US6673825 Urazole compounds useful as anti-inflammatory agents |
| 01/06/2004 | US6673806 Crystalline form II cabergoline |
| 01/06/2004 | US6673800 4,5,-dihydroisoxazolylakylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof |
| 01/06/2004 | US6673798 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 01/06/2004 | US6673796 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/06/2004 | US6673795 Pyrimidine, pyrazine and triazane derivatives |
| 01/06/2004 | US6673794 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 01/06/2004 | US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 01/06/2004 | US6673600 Transgenic C. elegans as a model organism for investigations on Alzheimer's disease |
| 01/06/2004 | US6673332 Test compounds screened for ability to inhibit or enhance binding of amyloid precursor protein with kinesin-i |
| 01/06/2004 | CA2341803C Controlled release formulation of divalproex sodium |
| 01/06/2004 | CA2301990C New substitute dimerized derivatives, process for preparing them, and pharmaceutical compounds containing them |
| 01/06/2004 | CA2232008C Use of epinastine for the treatment of pain |
| 01/06/2004 | CA2223588C Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 01/02/2004 | EP1375663A1 Novel protein, dna thereof and use of the same |
| 01/02/2004 | EP1375653A1 Dietary supplements for regulating the central nervous system |
| 01/02/2004 | EP1375503A1 Dioxino derivatives and their use as dopanine agonists |
| 01/02/2004 | EP1374952A1 Use of flumazenil in developing a drug for the treatment of alcohol dependence |
| 01/02/2004 | EP1374899A1 Remedies for post-traumatic stress disorder |
| 01/02/2004 | EP1374898A1 Remedies for nerve damages |
| 01/02/2004 | EP1374887A1 Novel agents for ameliorating motor disorder |
| 01/02/2004 | EP1374886A2 Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 01/02/2004 | EP1374870A1 Medication for the treatment or prevention of migraine |
| 01/02/2004 | EP1373905A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents |
| 01/02/2004 | EP1373559A2 Identification of neural defects associated with the nucleosomal assembly protein 1l2 gene |
| 01/02/2004 | EP1373517A2 Human kinases |
| 01/02/2004 | EP1373516A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 01/02/2004 | EP1373513A2 Streptococcus pneumoniae proteins and nucleic acids |
| 01/02/2004 | EP1373504A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 01/02/2004 | EP1373503A2 Neurotrophic factors |
| 01/02/2004 | EP1373502A2 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373477A2 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor |
| 01/02/2004 | EP1373475A2 Immunotherapy based on dendritic cells |
| 01/02/2004 | EP1373319A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |
| 01/02/2004 | EP1373300A2 Novel use of a peptide class of compound for treating non neuropathic inflammatory pain |
| 01/02/2004 | EP1373269A1 Jun kinase inhibitors |
| 01/02/2004 | EP1373266A2 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 01/02/2004 | EP1373263A1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 01/02/2004 | EP1373262A2 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors |
| 01/02/2004 | EP1373258A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 01/02/2004 | EP1373257A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/02/2004 | EP1373256A1 Ccr5 antagonists useful for treating aids |
| 01/02/2004 | EP1373254A1 New process |
| 01/02/2004 | EP1373251A2 Non-imidazole compounds as histamine h3 antagonists |